Operator

Good day, and welcome to the Aurora Spine Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Adam Lowensteiner of Lytham Partners. Please go ahead.

Adam Lowensteiner
Lytham Partners, LLC

Thank you, Danielle. Welcome, everyone, and thank you for joining us today to conduct an update with investors and review the financial results for Aurora Spine for the fourth quarter and fiscal year 2025 that ended December 31, 2025. With us on the call representing the company today are Trent Northcutt, President and CEO of Aurora Spine; Matt Goldstone, Chief Commercial Officer; and Chad Clouse, Chief Financial Officer. Before we begin, I'd like to remind everyone that statements made during this course of this call may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Act of 1934. These statements reflect current expectations concerning future events and results. Words such as expect, intend, believe, may, will, should, could, anticipate and similar expressions are words that are used to identify forward-looking statements, but their absence does not mean a statement is not forward-looking.

These statements are not guarantees of future performance and are subject to risks and uncertainties and other important factors that could cause actual performance or achievements to be materially different from those projected. For a full discussion of these risks, uncertainties and factors, you are encouraged to read